These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32057199)

  • 1. [Current questions of multiple sclerosis: the secunder progressive form of the disease].
    Vécsei L
    Ideggyogy Sz; 2020 Jan; 73(1-2):7-14. PubMed ID: 32057199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis.
    Mariottini A; Stack EH; Nair G; Nozzoli C; Wu T; Marchi L; Boncompagni R; Repice AM; Fainardi E; Pasquale FD; Carlesi E; Saccardi R; Jacobson S; Massacesi L
    Mult Scler Relat Disord; 2024 Aug; 88():105745. PubMed ID: 38996712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Ouellette R; Treaba CA; Granberg T; Herranz E; Barletta V; Mehndiratta A; De Leener B; Tauhid S; Yousuf F; Dupont SM; Klawiter EC; Sloane JA; Bakshi R; Cohen-Adad J; Mainero C
    Brain; 2020 Oct; 143(10):2973-2987. PubMed ID: 32935834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
    Sorensen PS; Sellebjerg F; Hartung HP; Montalban X; Comi G; Tintoré M
    Brain; 2020 Sep; 143(9):2637-2652. PubMed ID: 32710096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
    Petzold A; Steenwijk MD; Eikelenboom JM; Wattjes MP; Uitdehaag BM
    Mult Scler; 2016 Aug; 22(9):1154-62. PubMed ID: 27207456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
    Stone LA; Cutter GR; Fisher E; Richert N; McCartin J; Ohayon J; Bash C; McFarland H
    J Neuroimaging; 2016 May; 26(3):296-302. PubMed ID: 26686343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
    Kearney H; Yiannakas MC; Samson RS; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Brain; 2014 Sep; 137(Pt 9):2456-68. PubMed ID: 24966048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.
    Dwyer MG; Bergsland N; Ramasamy DP; Jakimovski D; Weinstock-Guttman B; Zivadinov R
    J Neuroimaging; 2018 Sep; 28(5):490-495. PubMed ID: 29856910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse.
    Miranda Acuña J; Hidalgo de la Cruz M; Ros AL; Tapia SP; Martínez Ginés ML; de Andrés Frutos CD
    Mult Scler Relat Disord; 2017 Nov; 18():157-160. PubMed ID: 29141800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A current view on the MRI diagnosis of multiple sclerosis: an update of 2016 revised MRI criteria].
    Bryukhov VV; Krotenkova IA; Morozova SN; Krotenkova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):66-73. PubMed ID: 28617364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controversies in neurology: Diagnosis, follow up and therapy of multiple sclerosis with pathomechanismal approach].
    Vécsei L
    Ideggyogy Sz; 2021 Jul; 74(7-08):249-255. PubMed ID: 34370413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
    Gold R; Piani-Meier D; Kappos L; Bar-Or A; Vermersch P; Giovannoni G; Fox RJ; Arnold DL; Benedict RHB; Penner IK; Rouyrre N; Kilaru A; Karlsson G; Ritter S; Dahlke F; Hach T; Cree BAC
    J Neurol; 2022 Sep; 269(9):5093-5104. PubMed ID: 35639197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.